Skip to Main Content

A federal judge dealt the pharmaceutical industry a setback by declining to block a new California law that bans so-called pay-to-delay deals between drug makers, prompting an industry trade group to pursue an appeal with a higher court.

The move comes after the Association for Accessible Medicines filed a lawsuit two months ago to thwart the state law, which was the first in the nation to outlaw pay-to-delay deals. California officials explained the step was necessary in order to prevent drug companies from thwarting competition and maintaining higher prices for medicines.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED